Novel metal abstraction peptide (MAP) platform technology that delivers platinum to cancer cells by incorporating it into cancer-targeting proteins, thereby improving treatment while limiting side effects and damage to healthy cells
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Echogen plus 4809 other startups.
